Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × guselkumab × Gastrointestinal × Clear all

Status

No longer available 1 Completed 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Adenomatous Polyposis Coli 1

Interventions

regorafenib 2 zanidatamab 1 peginterferon alfa-2a 1 pegilodecakin 1 onvansertib 1 omburtamab I-131 1 guselkumab 1 derazantinib 1 avapritinib 1 Tenofovir 1 Melphalan 1 IMM-101 1 IFL protocol 1 HMPL-013 1 Everolimus 1 Brachytherapy 1 Bevacizumab 1 AM0010 1 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948398 2025-02-03

Post-Trial Access for Guselkumab in Participants With Familial Adenomatous Polyposis

Janssen Research & Development, LLC

No longer available

Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon ⚡